| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | President and CEO | Executive Chairman
3 companies
Westphal Christoph H serves as a 10% Owner at TCRX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 82 buys and 1 sell. Those positions are worth an estimated $23.7M at current prices.
The biggest single holding is TCRX (~$19.2M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 133,333 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2021 | TCRX Tscan Therapeutics, Inc. | 10% Owner | Buy | 133,333 | $15.00 | $1,999,995.00 | +11.6% | -38.4% | -66.9% | |
| Oct 16, 2018 | DCOY Salarius Pharmaceuticals, Inc. | 10% Owner | Sell | 3,212,861 | $0.92 | $2,941,052.96 | -100% | - | - | |
| Nov 8, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 7,000 | $7.31 | $51,170.00 | +0.2% | - | - | |
| Nov 7, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 8,870 | $5.70 | $50,559.00 | +0.2% | - | - | |
| Jun 23, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 2,700 | $11.28 | $30,456.00 | - | - | - | |
| Jun 22, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 5,700 | $11.05 | $62,983.00 | +0.2% | - | - | |
| Jun 20, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 6,000 | $11.18 | $67,050.00 | +0.2% | - | - | |
| Jun 16, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 5,800 | $11.17 | $64,786.00 | +0.2% | - | - | |
| Jun 14, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 5,900 | $11.54 | $68,080.00 | +0.2% | - | - | |
| Jun 10, 2016 | DCOY Salarius Pharmaceuticals, Inc. | President and CEO | Buy | 6,000 | $11.94 | $71,610.00 | +0.2% | - | - |